Amy Abernethy
艾米·阿伯内西
MD, PhD
Chief Medical Officer & President of Clinical Oncology (former); FDA Principal Deputy Commissioner (former)前首席医疗官兼临床肿瘤学总裁；前FDA首席副局长
👥Biography 个人简介
Amy Abernethy is a leading oncologist and health data scientist who pioneered the use of real-world evidence (RWE) from electronic health records to improve cancer care quality. As President of Clinical Oncology at Flatiron Health and later FDA Principal Deputy Commissioner, she shaped national policy on data-driven oncology outcomes.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Real-World Evidence Infrastructure
Built Flatiron Health's oncology EHR data platform, enabling large-scale real-world studies of treatment outcomes across diverse cancer types that inform quality standards and regulatory decisions.
FDA Regulatory Science
As FDA Principal Deputy Commissioner (2019–2021), advanced frameworks for using real-world data in cancer drug approvals, accelerating access to effective therapies while maintaining safety standards.
Patient-Centered Outcomes Research
Led initiatives embedding patient-reported outcomes into routine oncology practice, demonstrating that electronic PRO collection improves symptom management and overall survival.
Representative Works 代表性著作
Electronic Patient-Reported Data Collection in Cancer Clinical Practice
Journal of Clinical Oncology (2022)
Demonstrated feasibility and clinical impact of routine ePRO collection in oncology practices using real-world data infrastructure.
Characterization of Real-World Metastatic Non-Small-Cell Lung Cancer Patient Populations
JAMA Oncology (2021)
Landmark RWE study describing treatment patterns and outcomes in mNSCLC across a diverse national cohort.
The Promise of Real-World Data for Cancer Quality Measurement
New England Journal of Medicine (2020)
Outlined how EHR-derived real-world data can transform quality measurement and outcomes research in oncology.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 艾米·阿伯内西 的研究动态
Follow Amy Abernethy's research updates
留下邮箱，当我们发布与 Amy Abernethy（Flatiron Health / Former FDA Principal Deputy Commissioner）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment